ANDA 84737, held by Watson Labs. Hydrocortisone Sodium Succinate.
As of Nov 16, 2026, ANDA 84737 (Hydrocortisone Sodium Succinate), held by Watson Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Hydrocortisone Sodium SuccinateEQ 250MG BASE/VIAL · injectable;injection | Hydrocortisone Sodium Succinate | Discontinued |
| Hydrocortisone Sodium SuccinateEQ 100MG BASE/VIAL · injectable;injection | Hydrocortisone Sodium Succinate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters